Related Experiment Video
Updated: Jun 14, 2025

11:27
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
16.6K
Lipid metabolism reprogramming in renal cell carcinomas.
Mustafa Khalid Abduljabbar1, Mohammed Merza2,3, Abdulqader Aziz4
1Biotechnology Department, College of Applied Science, Fallujah University, Fallujah, Iraq.
Medical Oncology (Northwood, London, England)
|September 6, 2024
Summary
High intake of harmful fats promotes kidney cancer by disrupting lipid metabolism and inflammation. Understanding these mechanisms is crucial for developing targeted kidney cancer prevention and treatment strategies.
Area of Science:
- Oncology
- Metabolic Science
- Renal Medicine
Background:
- Rising global obesity rates correlate with increased kidney cancer incidence.
- Harmful fat consumption is implicated in various chronic diseases, including cancer.
- The specific molecular links between dietary fats and renal cell carcinoma require further elucidation.
Purpose of the Study:
- To investigate the mechanisms connecting harmful fat consumption to kidney cancer development.
- To identify key molecular pathways and biological processes involved in this correlation.
- To provide a foundation for targeted interventions against lipid-mediated renal tumorigenesis.
Main Methods:
- Comprehensive literature review of current research and clinical studies.
- Analysis of molecular pathways related to lipid metabolism and inflammation.
- Examination of signaling cascades influencing cell proliferation, apoptosis, and angiogenesis in renal tissues.
Main Results:
- Adipose tissue factors, inflammation, and dysregulated lipid metabolism create a pro-tumorigenic renal microenvironment.
- Harmful fats impact signaling pathways crucial for cancer progression, including proliferation and angiogenesis.
- Specific lipid mediators are identified as key contributors to renal carcinogenesis.
Conclusions:
- Elucidating the molecular link between lipid metabolism and kidney malignancies is vital.
- Findings support the development of targeted preventive and therapeutic strategies for kidney cancer.
- This research provides a basis for public health initiatives to reduce the impact of harmful fats on kidney health.
Related Concept Videos
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K

